Breakfast Innovation Theater (Non-Accredited): Long-Acting Injectables for the Treatment of Schizophrenia: A Molecular Perspective

Breakfast will be served. Seating is limited to 250 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs. Presenter: Kaitlynn Earls DNP, PMHNP-BC, APRN This presentation is provided by Johnson & Johnson.